Frecuencia y factores de riesgo para bacteriemia por enterobacterias productoras de betalactamasa de espectro extendido en pacientes de un hospital público de Lima, Perú
Bibliographic Data
| ID | 15534820 |
|---|---|
| Authors | Angelo Falconí Sarmiento (Universidad Peruana Cayetano Heredia, corresponding author), Monthy Nolasco Mejia (Universidad Peruana Cayetano Heredia), Alonzo Bedoya Rozas (Universidad Peruana Cayetano Heredia), Catherine Amaro Giraldo (Hospital Nacional Cayetano Heredia), Germán Málaga (0000-0002-7828-300X, Hospital Nacional Cayetano Heredia) |
| Year | 2018 |
| Volume | 35 |
| Issue | 1 |
| Pages | 62-62 |
| Publication date | 2018-04-05 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Revista Peruana de Medicina Experimental y Salud Pública (JOURNAL) |
| Journal identifiers | ISSN: 1726-4634 • E-ISSN: 1726-4642 |
| Publisher | National Institute of Health of Peru (PUBLISHER • PE) |
| DOI | 10.17843/rpmesp.2018.351.3601 |
| PMID | 29924279 |
| OpenAlex | W2795433576 |
| Language | ES |
| Citations received | 2 |
A cross-sectional study was conducted aimed at determining the frequency and the risk factors for bacteremia caused by extended-spectrum Beta-Lactamase (ESBL)-producing Enterobacteriaceae in patients hospitalized in a public hospital in Lima. The study included patients over 14 years of age, with positive blood cultures during their hospitalization in Hospital Nacional Cayetano Heredia in 2016. Patients were classified according to the isolated bacterium (ESBL-producing or not). Bacteremia was caused by ESBL-producing Enterobacteriacea in 50.6% of the cases; 55.8% and 32.6% by E. Coli and K. pneumoniae, respectively. No differences were found regarding co-morbidity, or prior antibiotic use (62.8% of bacteremia due to ESBLproducing strains and 57% in the non-producing strains [p=0.595]). Half of the bacteremia cases due to Enterobacteriaceae in hospitalized patients are produced by ESBL-producing Enterobacteriaceae and, of these, 40% are acquired in the community
Biology · Gynecology · Antibiotic Use and Resistance · Medicine · Nosocomial Infections in ICU · Pharmaceutical Practices and Patient Outcomes
| Unique citing works | 2 |
|---|---|
| Citations per year | 0,33 |
| Citation span | 2020 - 2026 (7) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 2 |